Ranitidine Hydrochloride | Mylan Institutional Inc. while Breastfeeding

Nutrients from the food that you eat passes to your breast milk. Its good idea to take healthy diet while breastfeeding. You may need to consume more calories per day to support healthy body system. Some time it gets necessary take medicine while you are breastfeeding and as other food items passes into breast milk, medicine passes as well hence it becomes obvious to understand its effects while breastfeeding. We have analyzed many medications and in this sheet we will present some fact and known information associated with Ranitidine Hydrochloride | Mylan Institutional Inc. while breast-feeding.

What is Ranitidine Hydrochloride | Mylan Institutional Inc. used for?


Ranitidine is indicated in: Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. No placebo-controlled comparative studies have been carried out for periods of longer than 1 year. The treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome and systemic mastocytosis). Short-term treatment of active, benign gastric ulcer. Most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. Studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. Maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. Placebo-controlled studies have been carried out for 1 year. Treatment of GERD. Symptomatic relief commonly occurs within 24 hours after starting therapy with ranitidine 150 mg two times a day. Treatment of endoscopically diagnosed erosive esophagitis. Symptomatic relief of heartburn commonly occurs within 24 hours of therapy initiation with ranitidine 150 mg 4 times daily. Maintenance of healing of erosive esophagitis. Placebo-controlled trials have been carried out for 48 weeks. Concomitant antacids should be given as needed for pain relief to patients with active duodenal ulcer; active, benign gastric ulcer; hypersecretory states; GERD; and erosive esophagitis.

Is using Ranitidine Hydrochloride | Mylan Institutional Inc. unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Ranitidine Hydrochloride | Mylan Institutional Inc. safe for breastfeeding
Active ingredient in Ranitidine Hydrochloride | Mylan Institutional Inc. is Ranitidine and based on our analysis of Ranitidine it appears that using Ranitidine Hydrochloride | Mylan Institutional Inc. is safe in breastfeeding. Below is analysis of Ranitidine while breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers Ranitidine is secreted in human milk. Caution should be exercised when ranitidine is administered to a nursing mother.

Ranitidine Hydrochloride | Mylan Institutional Inc. Breastfeeding Analsys


Ranitidine while Breastfeeding

Safe

CAS Number: 66357-35-5

Drug which is commonly used in pediatric therapy even for newborn treatment. Excreted in high amount into breast milk although infant intake is reportedly lower than usual therapeutic dose. No side effects on breastfed babies have been reported. Increase of Prolactin levels has been shown, yet it does not induce galactorrhea.


Ranitidine Hydrochloride | Mylan Institutional Inc. Breastfeeding Analsys - 2


Ranitidine while Breastfeeding

CAS Number: 66357-35-5

Although interpatient variability exists, the dose of ranitidine in breastmilk is less than the dose used in newborn infants. Maternal ranitidine would not be expected to cause any adverse effects in breastfed infants. No special precautions are required.


Is Ranitidine Hydrochloride | Mylan Institutional Inc. safe while breastfeeding

I am nursing mother and I have already used Ranitidine Hydrochloride | Mylan Institutional Inc., what should I do?

As usage of Ranitidine Hydrochloride | Mylan Institutional Inc. is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Ranitidine Hydrochloride | Mylan Institutional Inc. else no further action is required.


My health care provider has asked me to use Ranitidine Hydrochloride | Mylan Institutional Inc., what to do?

Usage of Ranitidine Hydrochloride | Mylan Institutional Inc. is safe for nursing mothers and baby, No worries.


If I am using Ranitidine Hydrochloride | Mylan Institutional Inc., will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Ranitidine Hydrochloride | Mylan Institutional Inc. in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week